Abbott recently reported year over year sales of $10.6bn in its third quarter of 2024 ... UK facility and create up to 400 ...
The company says around six million people across 60 countries now use its Freestyle Libre glucose monitors which avoid the ...
CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...
Do you struggle to fall asleep at night, or regularly wake up feeling tired? If so, you might find answers by learning about ...
FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
Beta Bionics announced today that it closed a Series E preferred stock financing round worth a total of $60 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback